AKBM: Q2 revenue up 6%, Feed Ingredient sold for $590M, extraordinary dividend planned

About this update from Aker Biomarine Asa

Q2 saw the $590M sale of the Feed Ingredient business, with remaining operations focusing on human health and nutrition. Revenue grew 6% to $94M, EBITDA rose 35%, and an extraordinary dividend is planned post-transaction. Human Health Ingredient and international channels showed strong growth.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Aker Biomarine Asa